IRIS DUBETSKY: Open Payments
NPI 1194895649 · WALL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 17 payments from 10 companies in 2025. Trend: 2023 $468 · 2024 $652 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 4 | $225 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| MERZ NORTH AMERICA, INC. | 1 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Organon LLC | 2 | $29 |
| Journey Medical Corporation | 1 | $27 |
| PFIZER INC. | 1 | $16 |
| GENZYME CORPORATION | 1 | $16 |
| Almirall LLC | 1 | $16 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $12 |
Products named: DAXXIFY, COSENTYX, Xeomin, DUPIXENT, CIBINQO, Seysara, LIBTAYO, NEXPLANON.
Industry payments across NJ — which companies pay providers there.
